Oss, Netherlands

Herman Vromans

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Akzo Nobel N.v., Merck Sharp + Dohme B.v.. Active years: 1997-2014.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1997-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Herman Vromans

Introduction

Herman Vromans is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of drug delivery systems, holding a total of 5 patents. His work focuses on innovative solutions that enhance the effectiveness of medical treatments.

Latest Patents

Vromans' latest patents include a drug delivery system based on polyethylene vinylacetate copolymers. This system consists of one or more compartments containing a progestogenic compound dissolved in a thermoplastic polyethylene vinylacetate copolymer. Additionally, he has developed a contraceptive kit and hormone-replacement therapy kit that utilize this drug delivery system. Another patent discloses a combination preparation that simultaneously provides contraception and treatment for sexually transmitted diseases, also based on the same innovative drug delivery system.

Career Highlights

Throughout his career, Vromans has worked with prominent companies such as Akzo Nobel N.V. and Merck Sharp & Dohme B.V. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and drug delivery technologies.

Collaborations

Some of his notable coworkers include Wouter De Graaff and Janneke Sophie Groen. Their collaborative efforts have contributed to the advancement of Vromans' innovative projects.

Conclusion

Herman Vromans is a distinguished inventor whose work in drug delivery systems has the potential to significantly impact medical treatments. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…